| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/18/1997 | EP0778921A1 Pumping device |
| 06/18/1997 | EP0778889A2 Recombinant adenovirus comprising a chimeric penton base protein |
| 06/18/1997 | EP0778887A1 Rapid expansion method ("rem") for in vitro propagation of t lymphocytes |
| 06/18/1997 | EP0778778A1 Probiotic compositions |
| 06/18/1997 | CN1152251A Isolated nucleic acid sequence coding for a tumor rejection antigen presented by HLA-A2 |
| 06/18/1997 | CN1151891A Chinese medicine prepn for psoriasis and its prepn |
| 06/18/1997 | CN1151882A Mailetong capsule for promoting blood circulation |
| 06/18/1997 | CN1151879A Chinese medicine granule for acne |
| 06/18/1997 | CN1151867A Bee glue powder and its prodn |
| 06/18/1997 | CN1151843A Healthy silver carp food and its extraction |
| 06/18/1997 | CN1035184C Water-soluble medium molecular weight extractant from animal thymus gland |
| 06/17/1997 | US5639876 Encoding protein capable of selectively binding to immune serum which inhibits helminth development |
| 06/17/1997 | US5639730 Heating in presence of a tenside |
| 06/17/1997 | US5639725 Angiostatin protein |
| 06/17/1997 | US5639654 Process for creating a skin substitute and the resulting skin substitute |
| 06/17/1997 | US5639600 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
| 06/17/1997 | US5639501 Separation of minerals from whey permeate |
| 06/17/1997 | US5639467 Electrostatic process for manufacturing coated transplants and product |
| 06/17/1997 | US5639275 Capsule containing genetically engineered cells |
| 06/12/1997 | WO1997020835A1 Discodermolide compounds and pharmaceutical compositions containing them for cancer therapy |
| 06/12/1997 | WO1997020570A1 Non-immunogenic and toleragenic platelet and red blood cell compositions |
| 06/12/1997 | WO1997020569A2 Bioartificial devices and cellular matrices therefor |
| 06/12/1997 | WO1997015655A3 New artificial tissue, method for the production and the use thereof |
| 06/12/1997 | WO1997014964A3 Patient-specific immunoadsorbents for extracorporal apheresis and methods of producing said immuno-adsorbers |
| 06/12/1997 | WO1997012972A3 Regulated genes and uses thereof |
| 06/12/1997 | WO1997011667A3 Therapeutic applications using horse serum |
| 06/12/1997 | DE19543513A1 Agent for treating human immuno-deficiency virus infection |
| 06/12/1997 | CA2239574A1 Non-immunogenic and toleragenic platelet and red blood cell compositions |
| 06/11/1997 | EP0777740A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777739A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777736A1 Functional modified hsv1-tk |
| 06/11/1997 | EP0777686A1 Trophic factors for central nervous system regeneration |
| 06/11/1997 | EP0777641A1 Anti-inflammatory preparation |
| 06/11/1997 | EP0777494A1 Human chemokine polypeptides |
| 06/11/1997 | EP0777488A1 Composition and method for allogeneic mononuclear cell immunotherapy |
| 06/11/1997 | EP0777473A1 Compositions and methods for the control of smoking |
| 06/11/1997 | CN1151320A Pus drawing-out ointment |
| 06/11/1997 | CN1151292A Medicinal preparation for treatment of tumour |
| 06/11/1997 | CN1151290A Hydrolized pearl shellfish meat and similar livings and method of making them into oral liquid |
| 06/11/1997 | CN1151289A Medicine for treatment of cerebrovascular and cardiovascular and around vessel disease and its prodn. tech. |
| 06/10/1997 | US5637345 Freeze-drying, grinding |
| 06/10/1997 | US5637323 Administering interleukin |
| 06/10/1997 | US5637321 Water insoluble collagen |
| 06/05/1997 | WO1997020054A1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 06/05/1997 | WO1997020047A1 Methods and compositions for the diagnosis and treatment of cancer |
| 06/05/1997 | WO1997019695A1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/05/1997 | WO1997019689A1 Absorbable dietary composition for improving the biological balance of intestinal tract flora |
| 06/05/1997 | WO1997019687A1 Methods of production and use of liquid formulations of plasma proteins |
| 06/05/1997 | WO1997019683A1 Hydrolysis-optimized lipid emulsions and use thereof |
| 06/05/1997 | WO1997010334A3 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 06/05/1997 | WO1996039530A3 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof |
| 06/05/1997 | DE19648566A1 Isotonic lipid emulsion for parenteral application for nourishment, |
| 06/05/1997 | CA2239206A1 Methods of production and use of liquid formulations of plasma proteins |
| 06/05/1997 | CA2238829A1 Methods and compositions for the diagnosis and treatment of cancer |
| 06/05/1997 | CA2236157A1 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/04/1997 | EP0776907A2 Process for producing platelet factor-4 |
| 06/04/1997 | EP0776337A1 Growth differentiation factor-11 |
| 06/04/1997 | EP0776217A1 A method of treating a patient with a biologically active compound |
| 06/04/1997 | EP0776214A1 Antibacterial composition containing multimeric alpha-lactalbumin |
| 06/04/1997 | EP0776161A1 A method of selectively destroying neoplastic cells |
| 06/04/1997 | CN1151186A Thymidine kinase mutants |
| 06/04/1997 | CN1151167A Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 06/04/1997 | CN1150910A Osteophytosis pill and its compounding method |
| 06/04/1997 | CN1150909A Carsickness plaster and carsickness drug |
| 06/04/1997 | CN1150891A Selenium honey and its preparation technology |
| 06/04/1997 | CN1035040C Preparation method of thymus histone from baby pig |
| 06/03/1997 | US5635399 Retroviral vectors expressing cytokines |
| 06/03/1997 | US5635202 Micro-encapsulated lactobacilli for medical applications |
| 06/03/1997 | US5635178 Inhibition of complement mediated inflammatory response using monoclonal antibodies specific for a component forming the C56-9 complex which inhibit the platelet or endothelial cell activating function of the C56-9 complex |
| 05/29/1997 | WO1997019169A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | WO1997019110A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | WO1997018842A1 A biologic material comprising an efficient culture of bone marrow stem cells partially or completely differentiated into connective tissue cells and a three-dimensional biocompatible and biodegradable matrix consisting of a hyaluronic acid derivative |
| 05/29/1997 | WO1997018836A1 Virus replication inhibitor |
| 05/29/1997 | WO1997018822A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | CA2238404A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | CA2238176A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | CA2238010A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/28/1997 | EP0775493A2 Extracorporeal xenogeneic organ perfusion following antibody depletion by immunoapheresis |
| 05/28/1997 | EP0775213A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 05/28/1997 | EP0775209A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 05/28/1997 | EP0775203A1 Method of gene therapy using dna vectors without selection marker gene |
| 05/28/1997 | EP0775200A1 Recombinant kat enzyme and process for its preparation |
| 05/28/1997 | EP0775197A1 Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor |
| 05/28/1997 | EP0775010A1 Blood collection system deriving instantaneous component yield |
| 05/28/1997 | EP0775008A1 Blood processing systems and methods which restrict in flow of whole blood to increase platelet yields |
| 05/28/1997 | EP0775007A1 Enhanced yield blood processing systems with angled interface control surface |
| 05/28/1997 | EP0775005A1 Blood processing systems controlled by apparent hematocrit |
| 05/28/1997 | EP0774981A1 Injectable non-immunogenic cartilage and bone preparation |
| 05/28/1997 | EP0609255B1 Method and composition for determining the immunological activity of bioactive substances |
| 05/28/1997 | CN1150840A A method for detecting presence of mycobacterium species and kit and antibodies for use therein |
| 05/28/1997 | CN1150805A Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/28/1997 | CN1150760A Methods for inducing T cell tolerance to tissue or organ graft |
| 05/28/1997 | CN1150600A Health-care drinking wine containing spirulina components |
| 05/28/1997 | CN1150545A Tengxiling fumigant |
| 05/28/1997 | CN1150542A Xueyakang medicine for external use |
| 05/28/1997 | CN1150524A Physiologically active agent for fish and feed additive for fish cultivation |
| 05/28/1997 | CN1034985C Oral composite of traditional Chinese medicine for curing cancer |
| 05/27/1997 | US5633285 Cytoprotective wound healing compositions and methods for preparing and using same |
| 05/27/1997 | US5633227 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| 05/27/1997 | US5633130 Zwitterionic buffer |